FEBS Open Bio. 2023 Aug;13(8):1540. doi: 10.1002/2211-5463.13664. Epub 2023 Jul 6.
https://doi.org/10.1002/2211-5463.13221 The above article, published online on 08 June 2021 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the Editor-in-Chief Miguel De la Rosa, FEBS Press, and John Wiley and Sons Ltd. The retraction has been agreed following an investigation into concerns raised by a third party, which revealed inappropriate duplications between this and articles that were either previously published or published later in the same year [1-9]. Thus, the editors consider the conclusions of this manuscript substantially compromised. [1] Zheng, X., Huang, M., Xing, L. et al. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer. Mol Cancer 19, 73 (2020). https://doi.org/10.1186/s12943-020-01183-9. [2] Li X, Wang H, Liu Z, Abudureyimu A. CircSETD3 (Hsa_circ_0000567) Suppresses Hepatoblastoma Pathogenesis via Targeting the miR-423-3p/Bcl-2-Interacting Mediator of Cell Death Axis. Front Genet. 2021 Sep 29;12:724197. doi: 10.3389/fgene.2021.724197. PMID: 34659347; PMCID: PMC8511783. [3] Du J, Zhong H, Ma B. Targeting a novel LncRNA SNHG15/miR-451/c-Myc signaling cascade is effective to hamper the pathogenesis of breast cancer (BC) in vitro and in vivo. Cancer Cell Int. 2021 Mar 31;21(1):186. doi: 10.1186/s12935-021-01885-0. PMID: 33952250; PMCID: PMC8097789. [4] Hong W, Xue M, Jiang J, Zhang Y, Gao X. Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC). J Exp Clin Cancer Res. 2020 Aug 3;39(1):149. doi: 10.1186/s13046-020-01648-1. PMID: 32746878; PMCID: PMC7397626. [5] Ren N, Jiang T, Wang C, Xie S, Xing Y, Piao D, Zhang T, Zhu Y. LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis. Aging (Albany NY). 2020 Jun 9;12(11):11025-11,041. doi: 10.18632/aging.103314. Epub 2020 Jun 9. PMID: 32516127; PMCID: PMC7346038. [6] Zheng Y, Liu L, Wang Y, Xiao S, Mai R, Zhu Z, Cao Y. Glioblastoma stem cell (GSC)-derived PD-L1-containing exosomes activates AMPK/ULK1 pathway mediated autophagy to increase temozolomide-resistance in glioblastoma. Cell Biosci. 2021 Mar 31;11(1):63. doi: 10.1186/s13578-021-00575-8. PMID: 33789726; PMCID: PMC8011168. [7] Lin H, Wang J, Wang T, Wu J, Wang P, Huo X, Zhang J, Pan H, Fan Y. The LncRNA MIR503HG/miR-224-5p/TUSC3 Signaling Cascade Suppresses Gastric Cancer Development via Modulating ATF6 Branch of Unfolded Protein Response. Front Oncol. 2021 Jul 26;11:708501. doi: 10.3389/fonc.2021.708501. PMID: 34381729; PMCID: PMC8352579. [8] Lu G, Li Y, Ma Y, Lu J, Chen Y, Jiang Q, Qin Q, Zhao L, Huang Q, Luo Z, Huang S, Wei Z. Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis. J Exp Clin Cancer Res. 2018 Nov 27;37(1):289. doi: 10.1186/s13046-018-0945-6. PMID: 30482236; PMCID: PMC6260744. [9] Zhao Y, Zheng R, Chen J, Ning D. CircRNA CDR1as/miR-641/HOXA9 pathway regulated stemness contributes to cisplatin resistance in non-small cell lung cancer (NSCLC). Cancer Cell Int. 2020 Jul 6;20:289. doi: 10.1186/s12935-020-01390-w. PMID: 32655321; PMCID: PMC7339514.
https://doi.org/10.1002/2211 - 5463.13221 上述文章于2021年6月8日在线发表于威利在线图书馆（wileyonlinelibrary.com），已由作者、主编米格尔·德拉罗萨、欧洲生物化学学会联合会出版社以及约翰·威利父子有限公司达成协议撤回。此次撤回是在对第三方提出的担忧进行调查后达成的，调查发现该文章与之前发表或同年晚些时候发表的文章之间存在不当重复[1 - 9]。因此，编辑们认为该手稿的结论受到了严重影响。[1]郑X，黄M，邢L等。由E2F1和EIF4A3介导的环状RNA circSEPT9促进三阴性乳腺癌的发生和发展。《分子癌症》19，73（2020）。https://doi.org/10.1186/s12943 - 020 - 01183 - 9。[2]李X，王H，刘Z，阿布都热依木A。环状RNA circSETD3（Hsa_circ_0000567）通过靶向miR - 423 - 3p/细胞死亡轴的Bcl - 2相互作用介质抑制肝母细胞瘤发病机制。《前沿遗传学》。2021年9月29日；12：724197。doi：10.3389/fgene.2021.724197。PMID：34659347；PMCID：PMC8511783。[3]杜J，钟H，马B。靶向新型长链非编码RNA SNHG15/miR - 451/c - Myc信号级联在体外和体内有效抑制乳腺癌（BC）发病机制。《癌症细胞国际》。2021年3月31日；21(1)：186。doi：10.1186/s12935 - 021 - 01885 - 0。PMID：33952250；PMCID：PMC8097789。[4]洪W，薛M，姜J，张Y，高X。环状RNA circ - CPA4/let - 7 miRNA/PD - L1轴调节非小细胞肺癌（NSCLC）中的细胞生长、干性、耐药性和免疫逃逸。《实验与临床癌症研究》。2020年8月3日；39(1)：149。doi：10.1186/s13046 - 020 - 01648 - 1。PMID：32746878；PMCID：PMC7397626。[5]任N，姜T，王C，谢S，邢Y，朴D，张T，朱Y。长链非编码RNA ADAMTS9 - AS2通过调节miR - 223 - 3p/NLRP3轴抑制胃癌（GC）发展并使化疗耐药的GC细胞对顺铂敏感。《衰老（奥尔巴尼纽约）》。2020年6月9日；12(11)：11025 - 11041。doi：10.18632/aging.103314。2020年6月9日在线发表。PMID：32516127；PMCID：PMC7346038。[6]郑Y，刘L，王Y，肖S，麦R，朱Z，曹Y。胶质母细胞瘤干细胞（GSC）衍生的含PD - L1外泌体激活AMPK/ULK1途径介导的自噬以增加胶质母细胞瘤对替莫唑胺的耐药性。《细胞生物科学》。2021年3月31日；11(1)：63。doi：10.1186/s13578 - 021 - 00575 - 8。PMID：33789726；PMCID：PMC8011168。[7]林H，王J，王T，吴J，王P，霍X，张J，潘H，范Y。长链非编码RNA MIR503HG/miR - 224 - 5p/TUSC3信号级联通过调节未折叠蛋白反应的ATF6分支抑制胃癌发展。《肿瘤前沿》。2021年7月26日；11：708501。doi：10.3389/fonc.2021.708501。PMID：34381729；PMCID：PMC8352579。[8]卢G，李Y，马Y，卢J，陈Y，姜Q，秦Q，赵L，黄Q，罗Z，黄S，魏Z。长链非编码RNA LINC00511通过诱导miR - 185 - 3p/E2F1/Nanog轴促进乳腺癌肿瘤发生和干性。《实验与临床癌症研究》。2018年11月27日；37(1)：289。doi：10.1186/s13046 - 018 - 0945 - 6。PMID：30482236；PMCID：PMC6260744。[9]赵Y，郑R，陈J，宁D。环状RNA CDR1as/miR - 641/HOXA9途径调节的干性有助于非小细胞肺癌（NSCLC）对顺铂的耐药性。《癌症细胞国际》。2020年7月6日；20：289。doi：10.1186/s12935 - 020 - 01390 - w。PMID：32655321；PMCID：PMC7339514。
